Cinacalcet Hydrochloride Tablet
Product Images NDC 65162-155

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet Hydrochloride (NDC 65162-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A7c316fa-figure-01 (Cinacalcet Tablets 1)

Chemical structure of Cinacalcet Hydrochloride, showing its molecular components including aromatic rings, a trifluoromethyl group, and hydrochloride salt.*

FDA Label Image

A7c316fa-figure-02 (Cinacalcet Tablets 2)

A line graph comparing iPTH levels (pg/mL) over 26 weeks between Cinacalcet and placebo groups. The x-axis shows weeks (0 to 26), and the y-axis shows iPTH concentration (0 to 1000 pg/mL). Cinacalcet is represented by a red line showing a marked decrease in iPTH levels over time, while placebo, shown by a black dashed line, remains relatively stable near 700 pg/mL.*

FDA Label Image

A7c316fa-figure-03 (Cinacalcet Tablets 3)

A line graph comparing levels of Ca x P (mg/dL) over 26 weeks between Cinacalcet and placebo groups. The y-axis represents Ca x P levels, and the x-axis represents time in weeks. Cinacalcet shows a decrease in Ca x P levels compared to stable levels in the placebo group.*

FDA Label Image

A7c316fa-figure-04 (Cinacalcet Tablets 4)

A line graph showing serum calcium levels (mg/dL) over time in weeks for patients with parathyroid carcinoma. The x-axis represents time from 0 to 80 weeks including titration and maintenance phases, while the y-axis shows calcium levels ranging from 8 to 16 mg/dL. Data points with error bars indicate changes in calcium levels, decreasing initially during titration and stabilizing during maintenance.*

FDA Label Image

Figure 4 (Cinacalcet Tablets 5)

A line graph showing calcium levels (mg/dL) over several weeks for patients with intractable pHPT during titration and maintenance phases of treatment. Data points with error bars indicate calcium concentration measurements across different weeks, starting from baseline (B) and extending up to week 80.*

FDA Label Image

30mg Label (Cinacalcet Tablets 6)

Label for Cinacalcet Tablets 30 mg by Amneal Pharmaceuticals LLC. The label specifies each film-coated tablet contains 33 mg of cinacalcet hydrochloride equivalent to 30 mg of cinacalcet, with a supply of 100 tablets. Instructions include storage conditions and safety warnings. The label features the Amneal logo and barcode.*

FDA Label Image

60 mg Label (Cinacalcet Tablets 7)

Label for Cinacalcet Tablets 60 mg oral tablets by Amneal Pharmaceuticals LLC. The label states each film-coated tablet contains 66 mg of cinacalcet hydrochloride equivalent to 60 mg of cinacalcet. It includes storage instructions and a barcode. The label indicates a supply of 100 tablets and is marked Rx only.*

FDA Label Image

90mg Label (Cinacalcet Tablets 8)

Cinacalcet Tablets 90 mg oral film-coated tablets in a package containing 100 tablets. The label includes dosage strength, a sample image of a green tablet marked '213', and information on storage conditions. It is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label also features the Amneal logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.